Logo

American Heart Association

  74
  0


Final ID:

Commentary: Screening for Cardiac Amyloid

  • Ahmad, Faraz  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
    Faraz Ahmad: DO have relevant financial relationships ; Research Funding (PI or named investigator):Pfizer:Past (completed) ; Consultant:AstraZeneca:Past (completed) ; Speaker:AstraZeneca:Past (completed) ; Speaker:Alnylam:Past (completed) ; Consultant:Alnylam Pharmceuticals:Active (exists now) ; Research Funding (PI or named investigator):Abiomed/Johnson and Johnson:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):Atman Health:Past (completed) ; Research Funding (PI or named investigator):Tempus:Active (exists now) ; Research Funding (PI or named investigator):Atman Health :Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Rewriting the Code for Cardiac Amyloid: Novel Identification, Treatment, and Cure

Monday, 11/10/2025 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Commentary: Mab Therapy for Cardiac Amyloid

Alexander Kevin, Witteles Ronald

Improving Detection of Transthyretin Cardiac Amyloidosis with AI: A Single-Arm Multicenter Trial

Jain Sneha, Brown Kathleen, Ramlall Vijendra, Nicholas Nicholas, Elhadad Noemie, Rodriguez Fatima, Witteles Ronald, Goyal Parag, Homma Shunichi, Einstein Andrew, Maurer Mathew, Sun Tony, Elias Pierre, Poterucha Timothy, Pierson Emma, Roedan Oliver Francisco, Castillo Michelle, Wan Ningxin, Alishetti Shudhanshu, Hartman Heidi, Finer Joshua

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available